Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Arqt Stock Analysis Arcutis Biotherapeutics Drops 1.95 To 23.63 Amid Biotech Volatility 20260403 Is Momentum Building In Crescent Cap Ccap Stock Price At 12.37 Up 0.90 20260402 Can Quidelortho Corporation Qdel Stock Beat Estimates Price At 14.18 Up 2.38 20260413 Is Reinsurance Rga Stock A Buy Now Price At 205.84 Up 0.33 20260406 Daily Market Overview Us Indices Rise Broadly Nasdaq Leads Market Gains 20260409 1 Senstar SNT Stock Reverse Merger 135 20260418 Why Cenntro CENN is a smarter play than most realize Slight Loss 20260507 Criteo CRTO Stock Chart Pattern Insight Investors Pile In 20260418 MNDO MIND CTI Ltd Ordinary Shares climbs 286 percent after Q1 2025 earnings despite 93 percent yearoveryear revenue dip Kinder Morgan Inc KMI Robust Free Cash Flow Offset by Valuation Premium and Sector Headwinds What to expect from AGNC AGNCP stock in the coming months Q1 2026 EPS Beats Forecasts FPH Five Point reports 538 YoY Q4 2025 revenue drop shares fall 214 amid weak investor sentiment GABH Gabelli Equity Trust reports quarterly results unavailable investors await detailed portfolio performance update Why Perceptive PCSC is still under the radar Momentum Building 20260511 iShares Latin America 40 ETF ILF Rallies to AllTime Highs Amid Broader Thematic ETF Outperformance TACH Titan leadership shares updated merger search plans while prioritizing sustainable longterm shareholder returns The opportunity most miss about Eastern International ELOG 407 20260508 NPKI NPK International reports 203 percent Q4 2025 EPS beat but shares dip 07 percent amid missing revenue data How Tennant Company TNC margins compare to industry leaders Overhead Buying 20260506 Sam Altman Takes the Stand in HighStakes Trial Against Elon Musk Over OpenAIs Origins Palladyne AI PDYN Q1 2026 Results Miss Estimates EPS 023 vs 017 Sebi Explores Broader Intraday Borrowing Framework for Mutual Funds Zenas BioPharma ZBIO Q4 2025 Results Fall Short EPS 454 Revenue NA BlackBerry BB Q1 2026 Earnings Why the Beat Matters MFA Financial MFA Up 140 Is There More Room to Run 20260518 Aptevo APVO Q1 2026 Earnings Miss by Significant Key Takeaways YHN YHNAR Stock Analysis RangeBound Near 012 20260514 Fold Holdings FLD Gains 628 Support Holds at 121 20260520 Ultragenyx Pharmaceutical RARE Q1 2026 Earnings Miss Sparks Concern United Bancorp Inc UBCP Q4 2022 Earnings Solid EPS Performance Amid Quiet Release Aluminum Price Surge Pressures Major US Companies Amid Iran Conflict Duke Energy DUK Faces 5 Price Target Adjustment Amid Market Scrutiny Gaza Flotilla Detainee Allegations Could Affect Israels International Standing and Defense Sector French Open 2026 Player Dispute From Boycott Threat to Media Protest Financial Implications for Tennis Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Blocker to Innovation Trump Pressures Major Banks Over Alleged Discrimination Against Conservatives TVTX Q1 2026 Earnings EPS Misses Estimates Stock Declines on WiderThanExpected Loss Baytex Energy Q1 2026 Earnings Significant Miss as EPS Turns Negative WaFd Inc WAFDP Q1 2026 Earnings EPS Beats Estimates Amid Solid Operational Performance TDAY Q1 2026 Earnings Surprise Profit Defies Expectations MRCY Q1 2026 Earnings Massive EPS Beat Drives Stock Higher Cytokinetics CYTK Edges Higher as Shares Test Key Resistance Zone Southside Bancshares SBSI Shows Modest Gains as Stock Hovers Near Key Support Levels DWS Municipal Income Trust KTF Holds Steady Near 9 as Support and Resistance Levels Define Range TRG Latin America Acquisitions Corp Units TRGSU Holds Steady Near Trust Value as Market Awaits Business Combination STRD Strategy posts far worse than expected Q4 2025 earnings while shares edge slightly higher Should I hold or sell F5 FFIV stock today F5 Posts 195 Percent EPS Beat Tops Street Views Outdoor POWW Stock Technical Risk Signals Q1 2026 Profit Exceeds Views How Saba Capital BRW cash generation compares to earnings HALO Halozyme Therapeutics reports 375 revenue growth in Q1 but shares decline 175 despite beat